Interpace Biosciences, Inc. Stock
Stocks
IDXGD
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
OTC Markets
23:39:27 17/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 6.450 USD | 0.00% |
|
-1.83% | +4.86% |
| Market Cap | 35.73M 31.12M 29.46M 26.76M 50M 3.42B 50.25M 351M 136M 1.74B 134M 131M 5.57B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 34.41M 29.97M 28.37M 25.77M 48.15M 3.3B 48.39M 338M 131M 1.67B 129M 126M 5.36B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IDXGD | Delayed | |
Börse Stuttgart
| PF4 | Delayed | |
|
Boerse Muenchen
| PF4 | Real-time |
| 1 week | -1.83% | ||
| Current month | -14.80% | ||
| 1 month | -24.12% | ||
| 3 months | -21.58% | ||
| 6 months | -24.56% | ||
| Current year | +4.86% |
| 1 week | 5.97 |  | 6.53 |
| 1 month | 5.97 | | 8.15 |
| Current year | 5.15 | | 12 |
| 1 year | 3.85 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 50.25 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/8/26 | Free | Director | 69,252 | 0.2501% | ||
| 20/8/26 | Exercice | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 20/8/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.83% | +48.28% | +12.17% | 35.73M | |
| -1.52% | +9.45% | +100.16% | +605.05% | 52.8B | |
| -0.25% | +3.38% | +16.20% | +60.09% | 26.17B | |
| -1.94% | -0.67% | -13.53% | -37.98% | 6.89B | |
| -2.06% | +0.79% | -0.64% | +171.56% | 6.12B | |
| -1.44% | -1.03% | +16.33% | +62.42% | 3.36B | |
| -4.11% | +17.60% | -23.28% | +2,413.16% | 3.13B | |
| -1.06% | +12.38% | +125.81% | +48.81% | 2.56B | |
| +14.45% | +1.57% | +37.73% | +46.11% | 2.26B | |
| +3.13% | +7.32% | -11.11% | -53.18% | 1.85B | |
| Average | +0.50% | +6.43% | +29.59% | +332.82% | 10.52B | |
| Weighted average by Cap. | -0.91% | +8.98% | +56.90% | +401.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.87M 38.68M 35.15M 65.66M 4.49B 65.98M 461M 178M 2.28B 176M 172M 7.31B | 38.73M 33.73M 31.93M 29.01M 54.19M 3.71B 54.46M 380M 147M 1.88B 145M 142M 6.03B |
| Net income | 6.7M 5.84M 5.52M 5.02M 9.38M 642M 9.42M 65.8M 25.44M 326M 25.18M 24.62M 1.04B | 24.58M 21.4M 20.26M 18.41M 34.39M 2.35B 34.55M 241M 93.3M 1.2B 92.32M 90.26M 3.83B |
| Net Debt | 4.4M 3.83M 3.62M 3.29M 6.15M 421M 6.18M 43.15M 16.69M 214M 16.51M 16.14M 685M | -1.32M -1.15M -1.09M -990K -1.85M -127M -1.86M -12.98M -5.02M -64.34M -4.97M -4.86M -206M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | US$6.450 | 0.00% | 170 |
| 16/09/26 | US$6.450 | -0.77% | 512 |
| 15/09/26 | US$6.500 | +3.17% | 676 |
| 14/09/26 | US$6.300 | -3.08% | 5,920 |
| 11/09/26 | US$6.500 | -1.07% | 8,249 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXGD Stock
Select your edition
All financial news and data tailored to specific country editions
